Amazon healthcare exec: Doctors hate computers

Amy Baxter | | Health Exec | Digital Transformation

As technology continues to disrupt the healthcare space and advance care, doctors are increasingly seeing issues with more screen time and less face time with patients, according to Atul Gawande, the CEO of Amazon’s healthcare joint venture with Berkshire Hathaway and JPMorgan Chase.

Gawande penned an editorial for The New Yorker making the case that keeping healthcare facilities technologically up to date is taking doctors away from their primary responsibility of caring for patients. Instead, they are spending hours in mandatory training on electronic medical records that promise to facilitate better care, but create a new problem of burnout among clinicians.

“Something’s gone terribly wrong,” Gawande wrote. “... Somehow we’ve reached a point where people in the medical profession actively, viscerally, volubly hate their computers.”

See the full story below:

Why Doctors Hate Their Computers

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Generative AI isn’t changing everything for patients and providers—but it’s not leaving much unaffected, either
Antibiotics prescriptions: There’s a large-language model for that
4 important AMA insights into physician thinking on, behavior with healthcare AI
Global consortium: The future of AI in healthcare is dynamic—and demanding
Healthcare systems are proceeding apace with GenAI—and learning as they go
To prepare tomorrow’s doctors for evidence-based medicine, instruct today’s med students in dHealth and AI

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”